Searchable abstracts of presentations at key conferences in endocrinology

ea0081p537 | Adrenal and Cardiovascular Endocrinology | ECE2022

Management of persistent subclinical hypercortisolism post left adrenalectomy in a patient with primary bilateral macronodular adrenal hyperplasia with aberrant receptors

Moustaki Melpomeni , Papadimitriou Kasiani , Papanikolaou Vasiliki , Cherolidi Eleni , Rigana Maria , Kyriakopoulos Georgios , Kalogeris Nikolaos , Vryonidou Andromahi

Introduction: Endogenous subclinical hypercortisolism occurs in 5-30% of patients with adrenal incidentalomas. Adrenal adenoma is the commonest cause of autonomous cortisol secretion (ACS), while primary bilateral macronodular adrenal hyperplasia (PBMAH) is rare. In both, ACS results from activation of the cAMP/PKA pathway. This may be triggered by ligands, other than ACTH, acting upon aberrant G-protein coupled receptors (GPCRs), which may also control locally produced ACTH i...

ea0073aep823 | Late Breaking | ECE2021

A case of euglycaemic ketoacidosis and concomitant acute pancreatitis in a diabetic patient treated with SGLT2i and GLP-1RA

Moustaki Melpomeni , Kalogeris Nikolaos , Katsafyloudi Maria , Papanikola Nektaria , Rigana Maria , Spanou Loukia , Angelopoulos Theodoros , Kalantzis Ioannis , Vryonidou Andromahi

IntroductionGlucagon-like peptide 1 receptor agonists (GLP-1RA) and sodium-glucose cotransporter-2 inhibitors (SGLT2i) are the two novel classes of anti-diabetic agents with compelling efficacy, in terms of glucose-lowering and cardio-renal protection. Euglycemic diabetic ketoacidosis (EDKA) is a serious rare adverse effect of SLT2i while the use of GLP-1RA has been scarcely linked with acute pancreatitis in humans.Case presentatio...